Yale Cancer Center (YCC) and Smilow Cancer Hospital at Yale-New Haven have appointed Steven D. Gore, M.D., an internationally known hematologist, as director of hematologic malignancies at Smilow Cancer Hospital (SCH). Gore comes to Yale from The Johns Hopkins University School of Medicine (JHUSOM), where he was professor of oncology and a faculty member in the Program in Cellular and Molecular Medicine. He came to Yale in November.
“Dr. Gore’s national leadership on clinical trials for patients with leukemia and meylodysplastic syndromes and focus on translational research will elevate our hematology program,” says Madhav V. Dhodapkar, MBBS, the Arthur H. and Isabel Bunker Professor of Medicine, professor of immunobiology, and chief of hematology at YCC and SCH.
Gore is a member of the American Society of Hematology, the American Society of Clinical Oncology, and the American Association for Cancer Research, among other organizations. He received his B.S. from Yale College and his M.D. from Yale School of Medicine. He completed his residency in internal medicine at the University of Chicago Hospitals and Clinics and a fellowship in oncology at JHUSOM. He has authored more than 200 peer-reviewed articles and book chapters on hematologic malignancies and myelodysplastic syndromes.